Literature DB >> 10803747

Activation of synoviocytes.

U Müller-Ladner1, R E Gay, S Gay.   

Abstract

The evaluation of molecular pathways has revealed various novel insights into rheumatoid arthritis pathophysiology during the past year. In addition, there is an increasing tendency toward analysis not merely of a single mechanism but rather of data addressing a substantial part of the cascade of events leading to cellular activation. Because synovial fibroblasts are key cells involved in joint destruction, this review outlines the events that trigger or inhibit the crucial pathways leading to their aggressive behavior. Major topics include cellular and humoral interactions (frequently modulated by cytokines), intracellular signaling and upregulation of gene transcription, and the deleterious effects on articular homeostasis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10803747     DOI: 10.1097/00002281-200005000-00005

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  17 in total

1.  Imatinib mesylate inhibits proliferation of rheumatoid synovial fibroblast-like cells and phosphorylation of Gab adapter proteins activated by platelet-derived growth factor.

Authors:  H Kameda; H Ishigami; M Suzuki; T Abe; T Takeuchi
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

Review 2.  Are fibroblasts involved in joint destruction?

Authors:  T Pap; I Meinecke; U Müller-Ladner; S Gay
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

Review 3.  [Pathogenesis of RA: more than just immune cells].

Authors:  U Müller-Ladner; T Pap
Journal:  Z Rheumatol       Date:  2005-09       Impact factor: 1.372

4.  Cartilage destruction mediated by synovial fibroblasts does not depend on proliferation in rheumatoid arthritis.

Authors:  Christian A Seemayer; Stefan Kuchen; Peter Kuenzler; Veronika Rihosková; Janine Rethage; Wilhelm K Aicher; Beat A Michel; Renate E Gay; Diego Kyburz; Michel Neidhart; Steffen Gay
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

5.  Synovial tissue hypoxia and inflammation in vivo.

Authors:  C T Ng; M Biniecka; A Kennedy; J McCormick; O Fitzgerald; B Bresnihan; D Buggy; C T Taylor; J O'Sullivan; U Fearon; D J Veale
Journal:  Ann Rheum Dis       Date:  2010-05-03       Impact factor: 19.103

6.  Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.

Authors:  Tiffany J Dickerson; Erika Suzuki; Catherine Stanecki; Hyun-Seock Shin; Hong Qui; Iannis E Adamopoulos
Journal:  J Autoimmun       Date:  2012-08-03       Impact factor: 7.094

Review 7.  Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis.

Authors:  Ursula Fearon; Mary Canavan; Monika Biniecka; Douglas J Veale
Journal:  Nat Rev Rheumatol       Date:  2016-05-26       Impact factor: 20.543

8.  Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion.

Authors:  Cristina Teixeira de Matos; Louise Berg; Jakob Michaëlsson; Li Felländer-Tsai; Klas Kärre; Kalle Söderström
Journal:  Immunology       Date:  2007-05-22       Impact factor: 7.397

Review 9.  Actin cytoskeleton dynamics linked to synovial fibroblast activation as a novel pathogenic principle in TNF-driven arthritis.

Authors:  Y Vasilopoulos; V Gkretsi; M Armaka; V Aidinis; G Kollias
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

10.  p53 in rheumatoid arthritis synovial fibroblasts at sites of invasion.

Authors:  C A Seemayer; S Kuchen; M Neidhart; P Kuenzler; V Rihosková; E Neumann; M Pruschy; W K Aicher; U Müller-Ladner; R E Gay; B A Michel; G S Firestein; S Gay
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.